DJIA 17,079.57 -42.44 -0.25%
NASDAQ 4,557.70 -11.93 -0.26%
S&P 500 1,996.74 -3.38 -0.17%
market minute promo

Peregrine Pharmaceuticals (NASDAQ: PPHM)

1.65 -0.01 (-0.60%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PPHM $1.65 -0.60%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.64
Previous Close $1.66
Daily Range $1.63 - $1.66
52-Week Range $1.16 - $3.18
Market Cap $295.7M
P/E Ratio -7.55
Dividend (Yield) $0.00 (0.0%)
Volume 285,914
Average Daily Volume 933,959
Current FY EPS -$0.28

Sector

Healthcare

Industry

Drugs

Peregrine Pharmaceuticals (PPHM) Description

A biopharmaceutical company with a portfolio of clinical stage and pre-clinical product candidates using monoclonal antibodies for the treatment of cancer and viral diseases. Website: http://www.peregrineinc.com/

News & Commentary Rss Feed

3 Longtime Losers About to See Green?

These 3 biotechs have lost tons of money every year so far in the 21st century. But could profits be on the horizon?

Tekmira Pharmaceuticals Corp. Is More Than Just A Short-Term Trade

Peregrine Pharmaceuticals' Q4 Loss Narrower than Expected - Analyst Blog

Peregrine Pharmaceuticals' (PPHM) CEO Steven King on Q4 2014 Results - Earnings Call Transcript

Earnings Reaction History: Peregrine Pharmaceuticals Corporation, 50.0% Follow-Through Indicator, 16

Earnings Reaction History: Peregrine Pharmaceuticals Corporation, 50.0% Follow-Through Indicator, 16.5% Sensitive

Peregrine Earnings Today: 3 Questions That Need Answers

Here's what you should be looking for in Peregrine's second quarter earnings when they're released after the bell on July 14.

After-Hours Earnings Report for July 14, 2014 : OZRK, WTFC, PPHM, MILL, SAR, LEDS

After-Hours Earnings Report for July 14, 2014 : OZRK, WTFC, PPHM, MILL, SAR, LEDS

Earnings Scheduled For July 14, 2014

4 Stocks to Watch This Week

Let's look at the stocks that will be making news in the week ahead.

Could a Vaccine-Based Cancer Cure Be Around the Corner?

Earlier this week the Mayo Clinic unveiled a remarkable "cancer cure." Find out why this study could be such a game-changer.

See More PPHM News...

PPHM's Top Competitors

PPHM $1.65 (-0.60%)
Current stock: PPHM
AMGN $138.69 (0.62%)
Current stock: AMGN
GILD $107.51 (0.09%)
Current stock: GILD
BIIB $341.24 (-0.62%)
Current stock: BIIB